Table 1 Correlation between WWP2 expression and clinicopathologic factors in ALL patients.
Clinicopathologic Factors | Cases | WWP2 expression | P value |
---|---|---|---|
Gender | Â | Â | 0.162 |
 Male | 40 | 0.0731 ± 0.1059 |  |
 Female | 27 | 0.1242 ± 0.1648 |  |
Age | Â | Â | 0.154 |
 <42 | 33 | 0.0700 ± 0.1029 |  |
 ≥42 | 44 | 0.1166 ± 0.1567 |  |
FAB subtype | Â | Â | 0.016* |
 L1 | 5 | 0.0265 ± 0.0103 |  |
 L2 | 54 | 0.0767 ± 0.1076 |  |
 L3 | 8 | 0.2500 ± 0.2195 |  |
T/B subtype | Â | Â | 0.458 |
 T cell | 8 | 0.1491 ± 0.2235 |  |
 B cell | 59 | 0.0861 ± 0.1180 |  |
Blast cell (Bone marrow smear) | Â | Â | 0.493 |
 <32% | 33 | 0.0822 ± 0.1392 |  |
 ≥32% | 34 | 0.1048 ± 0.1299 |  |
Blast cell (Flow cytometry) | Â | Â | 0.032* |
 <32.8% | 33 | 0.0583 ± 0.0984 |  |
 ≥32.8% | 34 | 0.1279 ± 0.1551 |  |
WBC (*109/L) | Â | Â | 0.980 |
 <5.03 | 34 | 0.0933 ± 0.1272 |  |
 ≥5.03 | 33 | 0.0941 ± 0.1427 |  |
Hb (g/L) | Â | Â | 0.470 |
 <100 | 33 | 0.1058 ± 0.1236 |  |
 ≥100 | 34 | 0.0819 ± 0.1442 |  |
PLT (*109/L) | Â | Â | 0.370 |
 <131 | 32 | 0.1091 ± 0.1349 |  |
 ≥131 | 35 | 0.0795 ± 0.1335 |  |
BCR/ABL appearance | Â | Â | 0.586 |
 Positive | 16 | 0.0780 ± 0.0940 |  |
 Negative | 8 | 0.0531 ± 0.1273 |  |
Karyotype | Â | Â | 0.645 |
 Normal | 12 | 0.1827 ± 0.2074 |  |
 t (9;22) | 4 | 0.1546 ± 0.1324 |  |
 Complex | 4 | 0.1683 ± 0.1825 |  |
 Others | 7 | 0.0828 ± 0.1111 |  |